Simplex Trading’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1K Buy
4,400
+2,000
+83% +$16.6K ﹤0.01% 6493
2025
Q4
$25K Sell
2,400
-10,600
-82% -$106K ﹤0.01% 6269
2025
Q3
$116K Buy
13,000
+10,400
+400% +$91.3K ﹤0.01% 5575
2025
Q2
$33K Buy
2,600
+2,100
+420% +$31.6K ﹤0.01% 6321
2025
Q1
$12K Buy
500
+200
+67% +$5.94K ﹤0.01% 6993
2024
Q4
$10K Buy
300
+100
+50% +$4.51K ﹤0.01% 7211
2024
Q3
$9K Buy
+200
New +$10.2K ﹤0.01% 7278
2024
Q1
Sell
-32,000
Closed -$1.29M 9732
2023
Q4
$1.29M Buy
32,000
+31,000
+3,100% +$909K ﹤0.01% 2775
2023
Q3
$27K Buy
+1,000
New +$29.8K ﹤0.01% 6360

Other funds holding RXST

Simplex Trading's RXST Position: Q1 2026 in Review

Simplex Trading reduced its RxSight (RXST) stake by 61% in Q1 2026, selling an estimated $101K and leaving 7,673 shares worth $47.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5939.

Simplex Trading first reported a position in RXST in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.19M in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Simplex Trading held 7,673 shares of RxSight worth $47.3K as of Q1 2026.
  • Simplex Trading sold 12,125 RxSight shares in Q1 2026, an estimated $101K.
  • RxSight made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5939 holding.
  • Simplex Trading first reported a position in RxSight in Q4 2023 and has held it in 6 quarters since.
  • Simplex Trading's RxSight position peaked at $1.19M in Q4 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.